Use of Salivary Diurnal Cortisol as an Outcome Measure in Randomised Controlled Trials: a Systematic Review

Abstract

BackgroundDysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is associated with diverse adverse health outcomes, making it an important therapeutic target. Measurement of the diurnal rhythm of cortisol secretion provides a window into this system. At present, no guidelines exist for the optimal use of this biomarker within randomised controlled trials (RCTs).PurposeThe aim of this study is to describe the ways in which salivary diurnal cortisol has been measured within RCTs of health or behavioural interventions in adults.MethodsSix electronic databases (up to May 21, 2015) were systematically searched for RCTs which used salivary diurnal cortisol as an outcome measure to evaluate health or behavioural interventions in adults. A narrative synthesis was undertaken of the findings in relation to salivary cortisol methodology and outcomes.ResultsFrom 78 studies that fulfilled the inclusion criteria, 30 included healthy participants (38.5 %), 27 included patients with physical disease (34.6 %) and 21 included patients with psychiatric disease (26.9 %). Psychological therapies were most commonly evaluated (n = 33, 42.3 %). There was substantial heterogeneity across studies in relation to saliva collection protocols and reported cortisol parameters. Only 39 studies (50 %) calculated a rhythm parameter such as the diurnal slope or the cortisol awakening response (CAR). Patterns of change in cortisol parameters were inconsistent both within and across studies and there was low agreement with clinical findings.ConclusionsSalivary diurnal cortisol is measured inconsistently across RCTs, which is limiting the interpretation of findings within and across studies. This indicates a need for more validation work, along with consensus guidelines.Electronic supplementary materialThe online version of this article (doi:10.1007/s12160-015-9753-9) contains supplementary material, which is available to authorized users.

Saliva in the “Omics” era: A promising tool in paediatrics

“…Focus on salivary cortisol levels with respect to the hypothalamic‐pituitary‐adrenal (HPA) axis activity in children correlates well with the deregulation of HPA axis (Ryan, Booth, Spathis, Mollart, & Clow, ). Accordingly, assessment of cortisol in saliva is routinely measured as a biomarker of psychological stress.…”

Chiropractic Management of a Patient With Chronic Fatigue: A Case Report

“…24 However, the interpretation of saliva cortisol results was seen to be limited because of inconsistencies in measurement practice. 25 Analysis of the HPA axis in this patient, in the form of cortisol and DHEA-S measurements, was important not only with regard to her complaint of chronic fatigue but also in association with her inflammatory and autoimmune milieu. The HPA axis may have a strong modulation effect on the Th1 and Th2 activity balance.…”

Late-Night Salivary Cortisol: Cut-Off Definition and Diagnostic Accuracy for Cushing’s Syndrome in a Portuguese Population

“…20 The usefulness of LNSaC has been reported in several studies but diagnostic cut-off levels are highly dependent on the laboratory assay used. 4,5,7,[9][10][11][12]19,[21][22][23][24][25][26][27][28][29][30][31][32] Nevertheless, the discriminating power diminishes in the elderly population and tends to increase in presence of cardiovascular comorbidities as hypertension and diabetes. 33 Moreover, several different factors should be considered on the interpretation of SaC levels.…”